Yu et al (159) reported a mouse glioma model by in utero electroporation of CRISPR/Cas9 vectors targeting Nf1, Trp53, and PTEN with different variants of Pik3ca mutations. The gene discussed is PIK3CA; the disease is central nervous system cancer.